|
Proteomics is the
systematic study of the many and diverse properties of proteins in a parallel
manner with the aim of providing detailed descriptions of the structure,
function and control of biological systems in health and disease. Advances in
methods and technologies have catalyzed an expansion of the scope of biological
studies from the reductionist biochemical analysis of single proteins to
proteome-wide measurements. Proteomics and other complementary analysis methods
are essential components of the emerging 'systems biology' approach that seeks
to comprehensively describe biological systems through integration of diverse
types of data and, in the future, to ultimately allow computational simulations
of complex biological systems.
The targeting of
proteins to particular subcellular sites is an important principle of the
functional organization of cells at the molecular level. In turn, knowledge
about the subcellular localization of a protein is a characteristic that may
provide a hint as to the function of the protein. The combination of classic
biochemical fractionation techniques for the enrichment of particular
subcellular structures with the large-scale identification of proteins by mass
spectrometry and bioinformatics provides a powerful strategy that interfaces
cell biology and proteomics, and thus is termed 'subcellular proteomics'. In
addition to its exceptional power for the identification of previously unknown
gene products, the analysis of proteins at the subcellular level is the basis
for monitoring important aspects of dynamic changes in the proteome such as
protein transloction.
One of our research interests is
to document the extent to which a protein is modified and the temporal changes
in the modifications during disease can provide strategies for therapeutic
intervention. The techniques that catalog changes in gene expression, protein
levels, or modification due to disease or other cellular perturbations are
powerful methods of identifying potential targets for drug discovery.
|